PALO ALTO, Calif.--(BUSINESS WIRE)--twoXAR, Inc., a company pioneering digital approaches to drug discovery, today announced that the Stanford University-backed StartX Med program has selected the company for its Summer 2015 Accelerator Session. Founded in 2014, twoXAR (pronounced: “two-czar”) is transforming how large biological datasets are harnessed to accelerate the identification and validation of new medicines. The company’s DUMA™ platform rapidly evaluates massive public and proprietary